
Bliss GVS Pharma Q2 FY27 Results: Consolidated Net Profit ₹51.37 Crore on Total Income of ₹322 Crore
Bliss GVS Pharma (NSE: BLISSGVS) reported consolidated total income of ₹321.67 crore and net profit of ₹51.37 crore for the quarter ended 30 Sep 2026, it said in a filing on 29 Oct 2026. Standalone total income was ₹268.57 crore and standalone net profit ₹73.57 crore.
- Earnings
- Pharmaceutical and healthcare